SEC Form 4 · accession 0001682852-26-000157
Moderna, Inc. · MRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shannon Thyme Klinger
Officer — Chief Legal Officer
Period of report
Aug 27, 2026
Accepted (ET)
Aug 31, 2026 · 4:37 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001682852
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 27, 2026 | M | 774 | — | A | 74,335 | D | |
| Common Stock | Aug 27, 2026 | F | 375 | $149.66 | D | 73,960 | D | |
| Common StockF1 | Aug 28, 2026 | M | 329 | — | A | 74,289 | D | |
| Common Stock | Aug 28, 2026 | F | 160 | $142.77 | D | 74,129 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Aug 27, 2026 | M | 774 | D | — | — | Common Stock | 774 | 4,642 | D |
| Restricted Stock UnitsF1,F4 | — | Aug 28, 2026 | M | 329 | D | — | — | Common Stock | 329 | 658 | D |
Explanation of responses
- F1Restricted stock units convert into common stock on a one-for-one basis.
- F2Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
- F325% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- F425% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.